This program will provide ovarian cancer patients with up-to-date information on innovative treatment strategies.
Zoom Link Sent Upon Registration
Monday, September 28, 2026 at 8 pm ET/5 pm PT

This program will provide ovarian cancer patients with up-to-date information on innovative treatment strategies. We will also share updates on endometrial cancer and other gynecologic cancer advances. It also highlights opportunities to participate in clinical trials, while addressing prevention efforts for those with hereditary genetic risk and survivorship.
Bonus for our Embrace Community: We invite members of our Embrace community, those facing advanced ovarian cancer or metastatic breast cancer, to stay on at the end of the webinar for an intimate breakout session with our expert and Bonnie Beckoff, Director of Sharsheret Support Services.
Questions? Contact Rebecca Mendelsberg at [email protected].
Thank you to our webinar sponsor: 
The Embrace break out room is sponsored by: 
Speaker Bio
Dr. Beth Y. Karlan, is Professor and Vice Chair in the Department of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA. She holds the Nancy Marks endowed chair in Women’s Health Research and is the Director of Cancer Population Genetics at the UCLA Jonsson Comprehensive Cancer Center. Dr. Karlan’s research focuses on improving outcomes for women with ovarian and other gynecologic malignancies as well as better characterizing inherited cancer susceptibility syndromes. She has authored over 500 peer-reviewed research publications. For more than ten years she was Editor-in-Chief of the journals Gynecologic Oncology and Gynecologic Oncology Reports and now serves as Editor Emeritus of both journals. She is an American Cancer Society Clinical Research Professor and has served in many national leadership roles including president of the Society of Gynecologic Oncology. She has helped train a generation of physicians and scientists who are making their own contributions to medicine.
Dr. Karlan sits on Sharsheret’s Medical Advisory Board. She also served on the National Cancer Advisory Board and is a member of the National Academy of Medicine and the National Cancer Policy Forum. Her contributions have been recognized by her peers with multiple awards including a Lifetime Achievement Award from the International Society of Gynecologic Cancer, a Director’s Service Award from the National Cancer Institute and a Giant of Cancer Care in Gynecologic Malignancies from OncLive.
Disclaimer: By joining this program I understand and acknowledge that Sharsheret is not providing medical advice. Additionally, I release and waive Sharsheret from any liability in the event of any accident or injury I may incur either during the course of this webinar or in performing any of the activities discussed during the same.
All views shared on the webinar are of the speakers and are independent of the program sponsors. To the best knowledge of Sharsheret, no relationship exists between the sponsors and the speakers, and no payment has or will be made by the sponsor to the speakers in connection with this webinar.
